Cases & Deals

  • Home
  • Practices
  • Sanofi sells portfolio of established dental care brands to Septodont

Share

Sanofi sells portfolio of established dental care brands to Septodont

September 2021

Client(s) Sanofi

Jones Day advised Sanofi in the sale of an integrated portfolio of dental care brands and related medical devices to Septodont, a French privately-owned company headquartered near Paris. The divested portfolio includes four dental care brands Ultracain®, Rodogyl®, Birodogyl®, and Dontisolon®, as well as related medical devices, mostly marketed in Europe. This portfolio of high-quality medicines benefits patients both during and after dental operations, while covering most dental indications (anesthetics, anti-infective, and anti-inflammatory).

Contacts

Before sending, please note:

Information on www.jonesday.com is for general use and is not legal advice. The mailing of this email is not intended to create, and receipt of it does not constitute, an attorney-client relationship. Anything that you send to anyone at our Firm will not be confidential or privileged unless we have agreed to represent you. If you send this email, you confirm that you have read and understand this notice.